By eliminating the need to integrate clinical and radiomics features, the DTL signature streamlines the diagnostic process while maintaining robust performance, making it a highly effective tool for clinical decision-making.
Abstract
Rationale
AND
Objectives
Follicular neoplasms are difficult to classify by ultrasound, as they often present as thyroid adenomatoid nodules (TANU). Furthermore, fine-needle aspiration cytology (FNAC) exhibits limited accuracy in differentiating the nature of follicular lesions. This study aimed to develop and validate a novel model to optimize the workflow for distinguishing benign from malignant TANU.
Materials And Methods
This study enrolled 648 TANUs, which were divided into the training (Train), validation (Val), external test (Test), and surgically confirmed (SC) cohorts. Handcrafted radiomics features were extracted using PyRadiomics, and deep features were obtained using pretrained ResNet models. Robust features were selected via LASSO regression. The deep learning radiomics (DLR) signature integrated the deep transfer learning (DTL) and radiomics signatures. The combined signature integrated the DLR and clinical signatures. The performance of different signatures was evaluated using the Area Under the Curve (AUC). We also compared the diagnostic performance of our best signature with FNAC. Gradient-weighted Class Activation Mapping (Grad-CAM) visualizations were used to interpret the deep learning component.
Results
The DTL signature achieved the highest AUC of 0.959 in the Test cohort (the DLR, combined, radiomics, and clinical signatures were 0.937, 0.930, 0.835, and 0.599, respectively). Furthermore, the DTL signature outperformed FNAC in diagnostic accuracy, with higher specificity (96.2%) and overall accuracy (89.3%). Grad-CAM confirmed that key image regions significantly contributed to the signature's decisions.
Conclusion
By eliminating the need to integrate clinical and radiomics features, the DTL signature streamlines the diagnostic process while maintaining robust performance, making it a highly effective tool for clinical decision-making.
The FS-T2WI radiomics can reliably and non-invasively distinguish between benign and malignant parotid tumors, while the TabResNet framework offers a practical reference for building high-performance radiomics models in clinical practice.
Xu-Ran Mao, Yan-Ting Li, Wei Zhang et al.· Journal of cranio-maxillo-fa...· 0 citations
DL-based segmentation built upon SAM3 achieves satisfactory outcomes in automatic PTMC delineation from ultrasound images and the DLR model noninvasively predicts CLNM, supporting clinical decision-making for PTMC.
Jun Song, Yuan Zhang, X. Qin et al.· Academic Radiology· 0 citations
Purpose Differentiating between a choroidal melanoma and metastatic carcinoma to the choroid on cytological specimens presents significant diagnostic challenges due to subtle morphological differences in the sparse cells available in the sample and the increasing scarcity of specialist ocular pathologists. This study d...
Maxine Jackson, H. Kalirai, Rumana N. Hussain et al.· Investigative Ophthalmology...· 0 citations
Segmentation-guided peritumoral radiomics combined with machine learning represents an interpretable and promising adjunctive approach for ultrasound-based classification of salivary gland tumors.